Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Flutemetamol F 18 - GE Healthcare/University of Pittsburgh

Next Previous
X
Search
Drug Profile

Flutemetamol F 18 - GE Healthcare/University of Pittsburgh

Alternative Names: 18-F Flutemetamol; [18F]flutemetamol; AH-110690; F-18 PiB; F18 flutemetamol; Flutemetamol F18; Flutemetamol F18 Injection; GE 067; Pittsburgh compound B; Vizamyl

Latest Information Update: 05 Dec 2023

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator University of Pittsburgh
  • Developer GE Healthcare; University of Pittsburgh
  • Class Aniline compounds; Benzothiazoles; Fluorocarbons; Imaging agents; Radiopharmaceutical diagnostics; Small molecules
  • Mechanism of Action Positron-emission tomography enhancers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Alzheimer's disease

Most Recent Events

  • 16 Jul 2023 Efficacy data from phase III trial in Alzheimer's disease (diagnosis) presented at the Alzheimer's Association International Conference in July 2023 (AAIC-2023)
  • 23 Oct 2018 Launched for Alzheimer's disease (Diagnosis) in Czech Republic (IV)
  • 02 Oct 2018 GE Healthcare terminates phase III trial in Alzheimer's disease (Diagnosis, In elderly) in the Netherlands (EudraCT2016-002635-15)

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top